commande aldactone diamox sur le comptoir actos prix http://www.smwc.edu/?size=271371&price=2... augmentin comprar online strattera comprar en línea
http://kanab.utah.gov/licence.php?int=27... http://kanab.utah.gov/licence.php?int=27... where can i buy levitra
acheter allopurinol en ligne venlafaxine vente metronidazole prix
kamagra contrareembolso viagra apoteket kamagra butiken canadian tire pharmacie cialis sildenafil 100 mg viagra pillen
    levitra sans ordonance achat de viagra professional comparatif cialis viagra
    clomid preis vega 100 viagra finasteride comprare

Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study

Fri, Nov 8, 2013

Oral Cancer News

Source: The Lancet
Published: September 7, 2013
By: Aimée R Kreimer PhD, Christine M Pierce Campbell PhD, Hui-Yi Lin PhD, William Fulp MS, Mary R Papenfuss MS, Martha Abrahamsen MPH, Prof Allan Hildesheim PhD, Prof Luisa L Villa PhD, Jorge J Salmerón MD, Prof Eduardo Lazcano-Ponce PhD, Prof Anna R Giuliano PhD
 

Summary

Background

Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal cancers. These cancers disproportionately affect men, are increasing in incidence, and have no proven prevention methods. We aimed to establish the natural history of oral HPV infection in men.

Methods

To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study. A subset of the cohort who provided two or more oral rinse-and-gargle samples with valid HPV results and who completed a minimum of 2 weeks of follow-up were included in this analysis. Oral rinse-and-gargle samples and questionnaire data were obtained every 6 months for up to 4 years. Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method.

Findings

1626 men aged 18—73 years and with a median follow-up of 12·7 months (IQR 12·1—14·7) were included in the analysis. During the first 12 months of follow-up, 4·4% (95% CI 3·5—5·6; n=115 incident infections) of men acquired an incident oral HPV infection, 1·7% (1·2—2·5; n=53 incident infections) an oral oncogenic HPV infection, and 0·6% (0·3—1·1; n=18 incident infections) an oral HPV 16 infection. Acquisition of oral oncogenic HPV was significantly associated with smoking and not being married or cohabiting, but was similar across countries, age groups, and reported sexual behaviours. Median duration of infection was 6·9 months (95 % CI 6·2—9·3; n=45 cleared infections) for any HPV, 6·3 months (6·0—9·9; n=18 cleared infections) for oncogenic HPV, and 7·3 months (6·0—not estimable; n=5 cleared infections) for HPV 16. Eight of the 18 incident oral HPV 16 infections persisted for two or more study visits.

Interpretation

Newly acquired oral oncogenic HPV infections in healthy men were rare and most were cleared within 1 year. Additional studies into the natural history of HPV are needed to inform development of infection-related prevention efforts.

Funding

US National Cancer Institute, Merck Sharp & Dohme.

* This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

 

Print Friendly
Be Sociable, Share!
, , ,

Leave a Reply

You must be logged in to post a comment.